| Literature DB >> 35739545 |
Feng Huang1,2,3, Xiaofeng Li4, Zili Zhang1,2, Chunping Li1,2, Fei Ren5,6.
Abstract
BACKGROUND: The goal of this study was to determine the clinical outcomes of total arch replacement with frozen elephant trunk surgery and hybrid debranching surgery for acute type A aortic dissection patients.Entities:
Keywords: Acute type A aortic dissection; Clinical outcomes; Hybrid debranching; Total arch replacement
Mesh:
Year: 2022 PMID: 35739545 PMCID: PMC9229500 DOI: 10.1186/s13019-022-01920-9
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.522
Fig. 1Hybrid debranching procedure
Fig. 2Total arch replacement procedure
Preoperative data
| Variables | Total cohort (n = 177) | Propensity-matched cohort (n = 70) | ||||
|---|---|---|---|---|---|---|
| TAR | Hybrid | TAR | Hybrid | |||
| (n = 142) | (n = 35) | (n = 35) | (n = 35) | |||
| Male, n (%) | 116 (81.7) | 23 (65.7) | 0.068 | 23 (65.7) | 23 (65.7) | 1 |
| Age (y) | 53.9 ± 6.8 | 62.1 ± 6.2 | < 0.001 | 62.5 ± 6.8 | 62.1 ± 6.2 | 0.746 |
| Hypertension, n (%) | 129 (90.8) | 32 (91.4) | 0.983 | 31 (88.6) | 32 (91.4) | 0.983 |
| Diabetes, n (%) | 54 (38.0) | 12 (34.3) | 0.93 | 12 (34.3) | 12 (34.3) | 1 |
| CHD, n (%) | 24 (16.9) | 8 (22.9) | 0.461 | 7 (20.0) | 8 (22.9) | 1 |
| Smoking, n (%) | 40 (28.2) | 12 (34.3) | 0.519 | 10 (28.6) | 12 (34.3) | 0.819 |
| BMI, (kg/m2) | 24.8 ± 1.5 | 25.8 ± 1.6 | 0.002 | 25.1 ± 1.5 | 25.8 ± 1.6 | 0.322 |
| Liver dysfunction, n (%) | 3 (2.11) | 3 (8.6) | 0.069 | 3 (8.6) | 3 (8.6) | 1 |
| Renal dysfunction, n (%) | 2 (2.1) | 5 (14.3) | 0.006 | 4 (11.4) | 5 (14.3) | 1 |
| Ejection fraction (%) | 57.5 ± 2.9 | 57.8 ± 2.6 | 0.635 | 57.5 ± 2.9 | 57.8 ± 2.6 | 0.635 |
| AAD (mm) | 46.4 ± 7.1 | 47.5 ± 4.8 | 0.329 | 47.4 ± 5.1 | 47.5 ± 4.8 | 0.729 |
| ASD (mm) | 38.5 ± 6.0 | 37.4 ± 4.6 | 0.344 | 38.5 ± 6.0 | 37.4 ± 4.6 | 0.344 |
| Hydropericardium, n (%) | 7 (4.9) | 4 (11.4) | 0.288 | 3 (8.6) | 4 (11.4) | 1 |
| AVI, n (%) | 49 (34.5) | 6 (17.1) | 0.073 | 8 (22.9) | 6 (17.1) | 0.873 |
Y, years; mm, millimeter; TAR, total arch replacement; CHD, coronary artery heart disease; BMI, body mass index; AAD,aorta arch diam; ASD, aorta ascendens diam; AVI, aortic valve insufficiency
Intraoperative data
| Variables | Total cohort (n = 147) | Propensity-matched cohort (n = 70) | ||||
|---|---|---|---|---|---|---|
| TAR | Hybrid | TAR | Hybrid | |||
| (n = 142) | (n = 35) | (n = 142) | (n = 35) | |||
| Operation time (h) | 8.4 ± 1.3 | 6.5 + 0.8 | < 0.001 | 8.2 ± 1.45 | 6.5 + 0.8 | < 0.001 |
| CBP time (min) | 226 ± 27.7 | 142.1 ± 20.6 | < 0.001 | 232.3 ± 20.2 | 142.1 ± 20.6 | < 0.001 |
| ACC time (min) | 127.6 ± 15.2 | 95.5 ± 14.6 | < 0.001 | 131.3 ± 18.7 | 95.5 ± 14.6 | < 0.001 |
| AC time (min) | 39.0 ± 5.1 | 0 | < 0.001 | 37.8 ± 9.3 | 0 | < 0.001 |
h, hour; min, minute; CBP, cardiopulmonary bypass; ACC, aortic cross-clamp; CA, circulatory arrest; TAR, total arch replacement
Postoperative data
| Variables | Total cohort (n = 147) | Propensity-matched cohort (n = 70) | ||||
|---|---|---|---|---|---|---|
| TAR | Hybrid | TAR | Hybrid | |||
| (n = 142) | (n = 35) | (n = 35) | (n = 35) | |||
| ICU time (d) | 7.4 ± 2.0 | 2.8 ± 1.0 | < 0.001 | 6.8 ± 2.1 | 2.8 ± 1.4 | < 0.001 |
| Ventilation time(h) | 63.5 ± 19.7 | 18.5 ± 9.2 | < 0.001 | 59.7 ± 21.2 | 18.5 ± 9.2 | < 0.001 |
| Hospital stay time(d) | 17.9 ± 4.7 | 12.3 ± 4.3 | < 0.001 | 19.5 ± 6.4 | 12.3 ± 4.3 | < 0.001 |
| Erythrocyte volume(u) | 6.6 ± 2.4 | 4.2 ± 0.7 | < 0.001 | 4.5 ± 3.1 | 4.2 ± 0.7 | 0.103 |
| Plasma volume(ml) | 511.3 ± 190.1 | 420.0 ± 211.2 | 0.027 | 421 ± 152.1 | 420.0 ± 211.2 | 0.512 |
| Pulmonary infection, n (%) | 21 (29.6) | 4 (11.4) | 0.038 | 7 (20.0) | 4 (11.4) | 0.328 |
| Renal dysfunction, n (%) | 10 (14.1) | 3 (8.57) | 0.416 | 6 (17.1) | 3 (8.57) | 0.912 |
| TND, n (%) | 19 (26.8) | 3 (8.6) | 0.03 | 3 (8.6) | 3 (8.6) | 1 |
| PND, n (%) | 4 (5.6) | 0 | 0.152 | 3 (8.6) | 0 | 0.752 |
| 30-Day mortality, n (%) | 6 (8.5) | 1 (2.9) | 0.268 | 4 (11.4) | 1 (2.9) | 0.738 |
h, hour; d, day; u, unit; ml, milliliter; TND, Transient neurological dysfunction; PND, permanent neurological dysfunction; TAR, total arch replacement; ICU, intensive care unit
Fig. 3Survival function
2 years follow-up data
| Variables | Total cohort (n = 147) | Propensity-matched cohort (n = 70) | ||||
|---|---|---|---|---|---|---|
| TAR | Hybrid | P-value | TAR | Hybrid | P-value | |
| (n = 142) | (n = 35) | (n = 35) | (n = 35) | |||
| Distal arch levela, n (%) | 129 (90.8) | 34 (97.1) | 0.62 | 35 (100.0) | 34 (97.1) | 0.952 |
| Distal edge of the ET prosthesisa, n (%) | 87 (61.3) | 16 (45.7) | 0.138 | 18 (51.4) | 16 (45.7) | 0.931 |
| Renal artery levela, n (%) | 21 (14.8) | 7 (20.0) | 0.817 | 6 (17.1) | 7 (20.0) | 0.896 |
| Terminal abdominal aorta levela, n (%) | 13 (9.2) | 1 (2.9) | 0.205 | 0 (0) | 1 (2.9) | 0.321 |
| Internal leakage, n (%) | 13 (9.2) | 3 (8.6) | 0.914 | 1 (2.9) | 3 (8.6) | 0.310 |
| Reoperation, n (%) | 6 (4.2) | 1 (2.9) | 0.132 | 0 (0) | 1 (2.9) | 0.321 |
aFalse lumen thrombosis is defined as thrombosis of > 80% or complete obliteration of the false lumen